Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' reply

Mikhail N Kosiborod1, Russell Esterline2, Jan Oscarsson3

  • 1Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO 64111, USA; Department of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.

Abstract

No abstract available in PubMed .

Related Concept Videos